The intracellular pathways leading to mitochondrial activation and subsequent cell death in the ceramidemediated stress response have been intensively studied in recent years. Experimental evidence has been provided that ceramide-induced apoptosis is inhibited by overexpression of antiapoptotic proteins of the Bcl-2 family. However, the direct eect of proapoptotic gene products, e.g. Bax, on ceramide-induced death signalling has not yet been studied in detail. In the present work, we show by measurement of mitochondrial permeability transition, cytochrome c release, activation of caspase-3 and DNA fragmentation that ceramide-induced apoptosis is marginal in Bax-negative DU 145 cells. Reconstitution of Bax by generation of DU 145 cells stably expressing this proapoptotic factor, clearly enhanced ceramideinduced apoptosis at all levels of the mitochondrial signalling cascade. Using the broad-range caspase inhibitor zVAD-fmk and zDEVD-fmk, an inhibitor of caspase-3-like activities, we demonstrate that the ceramide-induced mitochondrial activation in Bax-transfected DU 145 cells is caspase-independent. On the other hand, apoptotic events located downstream of the mitochondria, e.g. DNA fragmentation, were shown to be caspase-dependent. This in¯uence of Bax on ceramide-induced apoptosis was con®rmed in another cellular system: whereas Bax-positive HCT116 wild type cells were very sensitive towards induction of cell death by C 2 -ceramide, sensitivity of Bax knock-out HCT116 cells was signi®cantly reduced. Thus, we conclude that Bax is a key activator of ceramide-mediated death pathways.
Introduction
Apoptosis is a morphologically and biochemically de®ned form of cell death which plays a role in dierent biological systems, such as physiological cell turnover, the immune system or embryonic development (Dragovich et al., 1998; Krammer, 2000; Meier et al., 2000) . The apoptotic programme can be triggered by dierent death stimuli, e.g. ionizing radiation (Lee and McKinnon, 2000; Peltenburg, 2000) , chemotherapeutic drugs Hannun, 1997; Wieder et al., 2001) , and by intracellular signalling molecules, e.g. ceramide (Obeid et al., 1993) . In previous studies, experimental evidence was provided that inactivation of apoptotic pathways may result in cytotoxic drug resistance. One of the main regulatory steps of apoptotic cell death is controlled by the ratio of anti-and proapoptotic members of the Bcl-2 family of proteins (for reviews see (Adams and Cory, 1998; Daniel, 2000) as a rheostat that determines the susceptibility to apoptosis. For example, overexpression of antiapoptotic Bcl-2 family members can tilt the rheostat towards survival thereby conferring drug resistance, at least in some cellular tumor model systems (Lotem and Sachs, 1993; Miyashita and Reed, 1993) . On the other hand, forced expression of proapoptotic Bax or Bak is sucient to increase the sensitivity of malignant breast cancer cells to apoptosis and to overcome drug resistance (Bargou et al., 1996; Radetzki et al., 2002) . These in vitro data are in line with studies from dierent laboratories which have demonstrated that the loss of Bax expression in carcinomas is a negative prognostic factor for response to cancer therapy (Krajewski et al., 1995; Sturm et al., 1999 Sturm et al., , 2001 . Furthermore, inactivation of the apoptosis machinery by loss of Bax may occur at the time of relapse after chemotherapy as has been shown in primary lymphoblasts of patients suering from childhood acute lymphoblastic leukemia (Prokop et al., 2000) .
Ceramide is an intracellular signalling molecule that is generated by agonist-induced hydrolysis of sphingomyelin in response to dierent stimuli, such as tumor necrosis factor a, Fas/CD95 ligand, interleukin-1, vitamin D 3 , etc. (for reviews, see Geilen et al., 1997b; Liu et al., 1997; Malisan and Testi, 1999) . Furthermore, ceramide accumulation inside the cell is observed after numerous stress stimuli, such as chemotherapeutic agents, radiation or heat. Accumulated ceramide modulates a number of biochemical and cellular responses to stress, including apoptosis and cell cycle arrest (Hannun and Luberto, 2000; Kolesnick and KroÈ nke, 1998) . It has been shown that cell-permeable, truncated ceramides, e.g. N-Acetylsphingosine (C 2 -ceramide), are able to mimic the cellular eects of several inducers of sphingomyelin hydrolysis on cell proliferation and dierentiation (Bielawska et al., 1992; Geilen et al., 1996) . The role of Bcl-2 family members in regulating ceramide-induced cell death has been described early and it is now clear that overexpression of antiapoptotic Bcl-2 inhibits ceramideinduced apoptosis (Geley et al., 1997; Zhang et al., 1996) . Bcl-2-dependent cell death has also been observed in Molt-4 cells which had been treated with synthetic ceramide analogues, namely N-Thioacetylsphingosine and the nonmetabolizable ceramide analogue, FS-5 (Wieder et al., 1997) . On the other hand, the in¯uence of proapoptotic Bax on ceramide-mediated cell death has only been indirectly studied in C6 rat glioma cells. It was shown that overexpression of Bax in these cells enhanced etoposide-induced apoptosis without aecting ceramide formation after etoposide treatment (Sawada et al., 2000b) . From their results the authors concluded that Bax promotes apoptosis regardless of ceramide formation. However, using cell permeable ceramides, we and others could provide experimental evidence that the susceptibility of dierent cell types for apoptosis signalling by ceramide is regulated by the Bax/Bcl-2 ratio (Raisova et al., 2001; Sawada et al., 2000a) . Nevertheless, a recent review suggested that ceramide activates mitochondrial permeability shift transition independently of Bax (Martinou and Green, 2001) .
In the present study, we therefore asked whether Bax expression is necessary for ceramide-mediated cell death. For this, we used the Bax-free prostate carcinoma cell line DU 145 and generated dierent clones stably expressing proapoptotic Bax. We show that DU 145 cells are insensitive towards treatment with C 2 -ceramide. In contrast, in DU 145 clones expressing dierent levels of Bax, C 2 -ceramide-induced apoptotic DNA fragmentation was markedly increased. The susceptibility of Bax-expressing DU 145 cells for ceramide was accompanied by a ceramide-induced Bax conformational change indicating that Bax in these cells is functional. Furthermore, we could demonstrate a mitochondrion-driven apoptotic response by measurement of mitochondrial permeability shift transition, release of cytochrome c into the cytosol and activation of caspase-3 after challenge of the cells with C 2 -ceramide. All steps in the apoptotic signalling cascade including DNA fragmentation were clearly enhanced in the Bax-transfected cell clones as compared with the mock-transfected cells. These data were corroborated by experiments performed in HCT116 cells expressing Bax and HCT116 cells where the bax gene was deleted. Interestingly, in Baxtransfected DU 145 cells, ceramide-induced mitochondrial permeability transition was not signi®cantly reduced by the broad spectrum caspase inhibitor zVAD-fmk or by the caspase-3 inhibitor zDEVDfmk. On the other hand, both inhibitors very eciently reduced ceramide-mediated DNA fragmentation which occurs downstream of mitochondrial permeability transition. Thus, we conclude that Bax mediates ceramide-induced mitochondrial activation in a caspase-independent manner.
Results
Characterization of human prostate carcinoma DU 145 cell clones DU 145 cells have been shown to be resistant against treatment with staurosporine and the absence of proapoptotic Bax in this cell line has been suggested as a possible underlying mechanism leading to inactivation of the apoptotic signalling cascade (Marcelli et al., 2000) . To prove this hypothesis we generated DU 145 cells stably expressing Bax. As shown in Figure 1a , mock-infected DU 145 cells do not express Bax whereas stable transfection of DU 145 cells by the use of the Bax-containing retroviral vector HyTK-Bax led to signi®cant accumulation of proapoptotic Bax in these cells. Stable expression of Bax in DU 145 cells did not signi®cantly alter the protein level of antiapoptotic Bcl-2 and Bcl-x L (Figure 1b,c) . Only a minor increase of the apoptosis-preventing Bcl-2 was observed in the Bax transfectants. Furthermore, actin was used as a loading control and actin levels did not dier in DU 145 cell clones (Figure 1d) . Thus, the intracellular rheostat of antiapoptotic and proapoptotic proteins in these cells mainly depends on the protein level of proapoptotic Bax. In recent studies, it has been shown that treatment of Bax-expressing cells with cell-permeable ceramides induces a Bax conformational change in the Nterminus (NT) of the protein through an early transitory rise in intracellular pH (Belaud-Rotureau et al., 2000) . To test this functional feature of reconstituted Bax in Bax-transfected DU 145 cells, we measured the Bax conformational change in our experimental system. In a ®rst set of experiments, challenge of Bax-transfected DU 145 cells with 100 mM C 2 -ceramide led to an exposure of the NT epitope as evidenced by a shift of the signal to higher¯uorescence intensities ( Figure 2b ) whereas Bax-free DU 145 mocktransfectants did not show this shift (Figure 2a) . In Bax-free DU 145 mock-transfectants, 100 mM C 2 -ceramide induced a subpopulation of cells with decreased¯uorescence upon bax-staining. These particles are smaller (as evidenced by forward and sideward scatter analysis) and their auto¯uorescence is decreased. Thus, this subpopulation contains cells which die by a Bax-independent mechanism, possibly by necrosis, after the insult (approx. 20%). In further experiments, using two dierent Bax-expressing DU 145 clones, ceramide-mediated induction of NT-Baxpositive cells was shown to be concentration-dependent (Figure 2c) . A signi®cant shift of¯uorescence intensity was already observed after treatment with 50 mM C 2 -ceramide. In the presence of 100 mM C 2 -ceramide, the number of NT-Bax-positive cells reached about 30 ± 40% of the total population (Figure 2c ). Thus, we concluded that the exogeneously expressed Bax in DU 145/bax clones is functionally active.
Bax expression sensitizes DU 145 cells for C 2 -ceramide-induced mitochondrial permeability transition, cytochrome c release, activation of caspase-3 and DNA fragmentation
Ceramide is an intracellular signalling molecule which induces apoptotic cell death most likely by a mechanism involving mitochondrial activation (Ghafourifar et al., 1999) . We thus measured ceramide-induced mitochondrial permeability transition in mock-and Bax-transfected DU 145 cells using JC-1 staining and¯ow cytometric analysis on the single cell level. As shown in Figure 3a , treatment of DU 145/mock control cells with 100 mM C 2 -ceramide led to a modest decrease of uorescence intensity of the cells as compared with medium control-treated DU 145/mock cells. Bax- Oncogene Ceramide-mediated apoptosis requires Bax C von Haefen et al transfected DU 145, however, were much more sensitive towards treatment with C 2 -ceramide and a prominent decrease of the mitochondrial membrane potential was observed in about 43% of the total cell population ( Figure 3b ). Additional experiments revealed that this Bax-dependent mitochondrial permeability transition after C 2 -ceramide treatment was concentration-dependent and could be detected in two dierent DU 145 clones stably overexpressing Bax (Figure 3c ). In additional experiments, we investigated the mitochondrial signalling cascade and found that ceramide-induced cytochrome c release after treatment with 100 mM C 2 -ceramide was signi®cantly increased in both DU 145/Bax cell clones as compared with the mock-transfected control ( Figure 4a ). The same was true when ceramideinduced processing of procaspase-3 was measured. As shown in Figure 4b , treatment of DU 145/Bax cells with 100 mM C 2 -ceramide led to the appearance of the active 17 kDa subunit of caspase-3 whereas only marginal amounts of the active caspase-3 subunit were detected in ceramide-treated DU 145 mock transfectants. We also asked whether enhanced mitochondrial signalling in Bax-transfected DU 145 cells would result in higher rates of apoptotic cell death in these cells. As expected, DU 145/mock cells were resistant towards 100 mM C 2 -ceramide and only 15.5% of the cells showed apoptotic DNA fragmentation (Figure 5a ). On the other hand, reconstitution of Bax increased DNA fragmentation after 100 mM C 2 -ceramide to 43.8% of the total cell population ( Figure 5b ) which corresponds well with the increased mitochondrial permeability transition in these cells. Again, further experiments showed that DNA fragmentation was strongly enhanced in both DU 145/ bax clones as compared with the mock-transfected control after challenge with 50 mM or 100 mM C 2 -ceramide ( Figure 5c ). Ceramide-mediated apoptosis requires Bax C von Haefen et al C 2 -ceramide-induced DNA fragmentation but not mitochondrial permeability transition is inhibited by the broad spectrum caspase inhibitor zVAD-fmk or by the caspase-3 inhibitor zDEVD-fmk Bax-induced mitochondrial activation has been shown to be mediated via a Bid-dependent pathway (Desagher et al., 1999; Eskes et al., 2000) which involves caspasecatalysed Bid cleavage during death receptor-induced cell death (Li et al., 1998) . To investigate whether ceramide-induced mitochondrial permeability transition in Bax-transfected DU 145 cells is caspase-dependent, we used the broad spectrum caspase inhibitor zVADfmk in our experimental system. In control experiments, we could demonstrate that 10 mM zVAD-fmk eciently inhibits Taxol-(caspase-3-dependent) as well as CD95-induced (caspase-8-dependent) apoptosis by 67% and 86%, respectively (data not shown). ZVADfmk is therefore a better inhibitor as compared with 10 mM zDEVD-fmk which inhibited Taxol-induced apoptosis by 45% and CD95-induced apoptosis by only 10% (data not shown). As depicted in Figure 6a , mitochondrial permeability transition was not signi®-cantly inhibited by 10 mM or 20 mM zVAD-fmk after treatment of DU 145/Bax cells with 100 mM C 2 -ceramide. The same was true when DU 145/Bax cells were challenged with 50 mM C 2 -ceramide (data not shown). At both ceramide concentrations, the percentage of cells displaying low Dc m was not signi®cantly reduced in the presence of the caspase inhibitor indicating that ceramide-induced mitochondrial permeability transition is caspase-independent. In contrast, 10 mM zVAD-fmk signi®cantly reduced epirubicininduced mitochondrial permeability transition by 30 ± 40% (Figure 6a ). This positive control shows that the inhibitor is eectively interfering with the caspasedriven mitochondrial ampli®cation loop of apoptosis that has been described earlier (Slee et al., 2000) . We also measured the in¯uence of zVAD-fmk on the Bax conformational change in DU 145/Bax cells after 100 mM C 2 -ceramide. In line with the results described above, zVAD-fmk did not signi®cantly reduce the percentage of NT-Bax-positive cells (7% inhibition of NT-Bax-positive cells by 10 mM zVAD-fmk and 0% inhibition by 20 mM zVAD-fmk, data not shown). In contrast, ceramide-induced DNA fragmentation in the presence of 10 mM and 20 mM zVAD-fmk was inhibited by approximately 85% (Figure 6b ) thereby providing additional evidence that this broad spectrum caspase inhibitor is highly eective in our experimental system. Furthermore, we repeated the inhibitor experiments described above using zDEVD-fmk, an inhibitor of caspase-3-like activities. 10 mM or 20 mM zDEVD-fmk did not reduce ceramide-induced mitochondrial permeability transition (Figure 7a ) thereby corroborating the results obtained with zVAD-fmk. On the other hand, incubation of ceramide-treated DU 145 cells in the presence of 10 mM or 20 mM zDEVD-fmk signi®cantly reduced DNA fragmentation (Figure 7b ). Taken together, we conclude from these results that ceramide-induced activation of Bax and mitochondrial permeability transition proceed in a caspase-independent manner whereas the execution of cell death downstream of the mitochondrion clearly depends on the activity of caspases, presumably caspase-3 (see also Figure 4b ).
C 2 -ceramide-induced apoptosis is inhibited by loss of Bax
To investigate the eect of Bax on ceramide-induced apoptosis in another cellular system, Bax knock-out cells (Bax 7/7) generated from human colorectal cancer HCT116 wild type cells (Zhang et al., 2000) were tested for ceramide-induced cell death. In contrast to the HCT116 wild type cells, these knock-out HCT116 cells do not express Bax protein as determined by Western blot analysis (Figure 8a, upper panel) . Further analysis revealed that antiapoptotic Bcl-x L protein levels were similar in HCT116 wild type and HCT116 Bax 7/7 cells (Figure 8a, lower panel) . After characterization of the cells, we treated HCT116 wild type and HCT116 Bax knock-out cells with increasing amounts of C 2 -ceramide and measured DNA fragmentation on the single cell level by¯ow cytometric analysis. As shown in Figure 8b , a strong reduction of ceramide-induced DNA fragmentation was observed in HCT116 Bax knock-out cells as compared with the Bax-expressing HCT116 wild type cells, especially at ceramide concentrations 450 mM. At higher concentrations of ceramide, however, the apoptosis rate of HCT116 wild type cells decreased, presumably because of unspeci®c, cytotoxic eects of the synthetic lipid analog leading to necrotic cell death (Figure 8b ). This also indicates that apoptotic cell death induced by ceramide depends on Bax while necrotic cell death might occur in a Bax-independent manner.
We also measured the mitochondrial membrane potential after challenge of HCT116 cells with 50 mM C 2 -ceramide: whereas the percentage of HCT116 wild type cells undergoing mitochondrial permeability transition reached 41.2+3.2% (n=3) only 22.7+ 3.4% (n=3) of the HCT116 Bax 7/7 cells showed mitochondrial permeability transition. The percentage of cells with low Dc m in medium control-treated HCT116 wild type cells was 11.6+0.5% (n=3) and 13.0+0.9% (n=3) in medium control-treated HCT116 Bax 7/7 cells. Thus, using Bax knock-out cells we clearly demonstrate that Bax plays a major role in ceramide-induced mitochondrial activation ®nally leading to apoptotic cell death.
Discussion
Ceramide is an intracellular signalling molecule that is produced by agonist-induced, receptor-mediated sphin- et al., 1995) . Furthermore, it has been shown that accumulation of ceramide also occurs after cytotoxic stress, e.g. treatment of cells with chemotherapeutic drugs (Lucci et al., 1999b; Perry et al., 2000) or radiation (Jarezou et al., 2001; Zhang et al., 2001) . Increased levels of intracellular ceramide induce cell dierentiation and/or apoptosis and reduce cell proliferation (for reviews, see Geilen et al., 1997b; Hannun and Luberto, 2000) . Up to now, several mechanisms have been proposed leading to resistance towards ceramide-induced stress, e.g. glucosylation of ceramide (Liu et al., 1999) , moulding of a multidrug-resistant phenotype (Lucci et al., 1999a) , or defects in apoptotic signalling cascades (Raisova et al., 2001) . As far as apoptotic signalling is concerned, it has been shown in dierent melanoma cell lines that ceramide-induced apoptosis proceeds via the mitochondrial pathway of apoptosis leading to release of cytochrome c (Raisova et al., 2000) , a cellular eect which had been ®rst described in an in vitro assay using isolated mitochondria (Ghafourifar et al., 1999) . Mitochondrial apoptosis is regulated by members of the Bcl-2 family of proteins (Adams and Cory, 1998; Kroemer and Reed, 2000) . Thus, it is not surprising that ceramide-induced mitochondrial activation is inhibited by antiapoptotic Bcl-2 thereby providing an explanation for the cytoprotective eect of Bcl-2 overexpression in cells which had been treated with cell-permeable ceramides (Smyth et al., 1996; Wieder et al., 1997; Zhang et al., 1996) . While the eect of Bcl-2 on ceramide-induced apoptosis has been intensively studied, only limited data are available on the role of proapoptotic Bax. Recent data, however, showed a positive correlation between the Bax/Bcl-2 ratio and the susceptibility of melanoma cells for ceramide-induced cell death (Raisova et al., 2001) . Furthermore, partial downregulation of Bax expression by the use of antisense oligonucleotides inhibited ceramide-induced apoptotic cell death in HL-60 cells (Kim et al., 2001) . In this line, our results that Bax-free DU 145 cells are insensitive towards challenge with truncated ceramides and that sensitivity can be restored by reconstitution of Bax give an important hint that proapoptotic Bax is an essential player in the ceramide stress response. This was con®rmed in another cellular system, and we could demonstrate that knock-out of Bax in HCT116 cells abrogates ceramide-induced apoptotic cell death, especially at ceramide concentrations 450 mM. At higher ceramide concentrations, however, HCT116 wild type cells were killed by a necrotic pathway or by slow cell death as outlined in a previous review (Blagosklonny, 2000) . Results indicating that ceramide may induce necrotic cell death at higher concentrations were also obtained in another study using the prostate cancer cell line LNCaP. In these cells, ceramide-induced cell death had both necrotic and apoptotic features (Engedal and Saatcioglu, 2001 ). Furthermore, we and others showed in previous studies that high ceramide concentrations induced caspase-independent cell death resembling necrosis which could not be inhibited by Bcl-2 (Smyth et al., 1996; Wieder et al., 1997; Zhang et al., 1996) . In this line, our data point out that the induction of apoptosis by ceramide depends on the presence of Bax while the unspeci®c, necrotic cell death induced at higher concentrations is executed independently from Bax and the activation of the mitochondrial pathway of apoptosis. Molecular ordering of ceramide formation, caspase activation and Bax/Bcl-2 expression during etoposide- induced apoptosis of C6 glioma cells revealed that ceramide functions as a mediator in this death pathway. Detailed analysis showed that ceramide treatment led to an increase of the Bax/Bcl-2 ratio followed by release of cytochrome c leading to downstream activation of caspase-9 and caspase-3 (Sawada et al., 2000a) , a signalling cascade that is also operational in Baxtransfected DU 145 cells. Furthermore, these data obtained in C6 glioma cells and other results in HL-60 cells (Kim et al., 2001 ) are in accordance with our ®nding that ceramide-induced mitochondrial activation in Baxtransfected DU 145 cells is caspase-independent. Thus, mitochondrial activation of DU 145/Bax cells was not reduced by the broad spectrum caspase inhibitor zVADfmk or by the caspase-3 inhibitor zDEVD-fmk. This indicates that Bax-mediated sensitization for ceramideinduced apoptosis upstream of the mitochondrion occurs directly, without requiring ampli®cation by a caspasedependent ampli®cation loop as in the case of death receptors or epirubicin-induced apoptosis. There are at least two mechanistic models which could explain this caspase-independent sensitization: (1) a direct physical interaction between ceramide and proapoptotic Bax leading to the N-terminal conformational change in the Bax protein and (2) an indirect mechanism involving ceramide-regulated phosphorylation of the proapoptotic Bcl-2 family member, Bad. The latter has been linked to the ability of ceramide to induce apoptosis in COS-7 cells (Basu et al., 1998) . In this study, however, the authors did not determine the Bax/Bcl-2 ratio which might be important since it has been shown that the BH3-only protein Bad failed to induce apoptosis in the absence of Bax (Zong et al., 2001) . Our results indicating that Bax represents a key regulatory element in ceramide-induced apoptosis might therefore link ceramide signalling through the Ras/Raf cascade to activation of Bax and downstream execution of the mitochondrial death pathway. On the other hand, evidence was provided that puri®ed, recombinant Bax opened the mitochondrial permeability transition pore in an in vitro assay using isolated mitochondria, and opening of the pore was potentiated by ceramide (Pastorino et al., 1999) . This argues in favor of a direct physical interaction between Bax and ceramide (or between ceramide and the mitochondrial membrane thereby facilitating insertion of Bax into the membrane) since this in vitro mitochondrial activation assay should not contain all the components of the Ras/Raf cascade.
In a recent review, Martinou and Green have put forward the hypothesis of a ceramide-mediated pathway of cell death which operates independently of Bax (Martinou and Green, 2001) . According to their model, ceramide functions as a`classical' opener of the permeability transition pore which is formed from a complex of the voltage-dependent anion channel, the adenine nucleotide translocator and cyclophilin D, plus several other proteins, at the contact sites between the mitochondrial outer and inner membranes. After opening of the permeability transition pore, the outer mitochondrial membrane ruptures, allowing release of proapoptotic proteins from the intermembrane space.
Ceramide may thereby damage a subpopulation of mitochondria, leading to apoptosis if the level of ATP produced by spared mitochondria is enough to activate the apoptosome. Interestingly, this model might indeed explain the induction of apoptotic cells by 100 mM ceramide in Bax-free DU 145 and HCT116 Bax7/7 cells which reached between 25% and 50% of the population. However, this model cannot account for the drastic Bax-dependent sensitization of the carcinoma cells for ceramide-induced mitochondrial activation and cell death at lower, more physiologically relevant concentrations of ceramide.
In summary, the present study provides evidence in two dierent cellular systems, i.e. reconstitution of Bax in Bax-negative DU 145 cells and knock-out of Bax in HCT116 cells, that Bax is a major player which dictates the execution of apoptosis after ceramide-induced stress. Upstream of the mitochondrion, this activation of Bax by ceramide is independent from caspase activities. Our data, together with the reports from other laboratories as outlined above, help to correct the model of a Baxindependent mitochondrial signalling pathway during ceramide-induced apoptosis that has been proposed recently (Martinou and Green, 2001 ).
Materials and methods

Materials
Monoclonal anti-human Bax antibody (clone YTH-2D2) recognizing a N-terminal peptide (amino acids 3 ± 16) was from Trevigen (Gaithersburg, MD, USA) and was used at 1 : 10 000. Polyclonal, protein G-puri®ed anti-human Bax antibody (Anti-Bax, NT) produced in rabbits immunized with a synthetic peptide corresponding to residues 1 ± 21 of human Bax and speci®cally detecting N-terminal Bax conformational change was from Upstate biotechnology (Lake Placid, NY, USA). Polyclonal anti-human actin antibody produced in rabbits was from Sigma (Deisenhofen, Germany) and was used at 1 : 100. Monoclonal anti-human Bcl-2 antibody developed against the synthetic peptide sequence 41 GAAPAPGIFSSQP 54 GC-COOH of human Bcl-2 (Clone bcl-2/100/D5) from Novocastra (Newcastle upon Tyne, UK) was used at 1 : 100. Monoclonal anti-human Bcl-x antibody developed against full length Bcl-x L lacking the N-terminal peptide (amino acids 1 ± 18) was from Transduction Laboratories (Lexington, KY, USA) and was used at 1 : 1000. Polyclonal rabbit anti-human caspase-3 (developed against human recombinant protein) and monoclonal mouse anti-human cytochrome c (Clone 7H8.2C12) antibodies were from PharMingen (Hamburg, Germany) and were used at 1 : 2000 and 1 : 1000, respectively. Secondary anti-rabbit and anti-mouse horseradish peroxidase (HRP)-conjugated antibodies were from Promega (Mannheim, Germany) and were used at 1 : 5000. RNase A was from Roth (Karlsruhe, Germany). N-Acetyl-sphingosine (C 2 -ceramide) was from Alexis (GruÈ nberg, Germany). C 2 -ceramide was stored as 40 mM stock solutions in ethanol at 7208C and diluted into growth media for experiments. Ethanol (vehicle) was added to controls and was present at 0.25% or less in the experiments. 0.25% ethanol did not induce signi®cant DNA fragmentation as compared with growth medium treated cells (data not shown). The broad spectrum caspase inhibitor zVAD-fmk and the caspase-3 inhibitor zDEVD-fmk (in which z stands for benzyloxycarbonyl and fmk for¯uoromethyl ketone) were from CalbiochemNovabiochem GmbH (Bad Soden, Germany) and were dissolved in dimethyl sulphoxide (DMSO) to give 20 mM stock solutions. According to the manufacturer, these inhibitors were synthesized as methyl esters to enhance cell permeability. 0.1% DMSO (vehicle) was added to controls. This treatment did not induce signi®cant apoptotic DNA fragmentation (data not shown).
Cell culture
Control retroviral vector-(HyTK-mock-transfected) and HyTK-Bax-transfected DU 145 prostate carcinoma cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 0.56 g/l L-glutamine, 100 000 U/l penicillin and 0.1 g/l streptomycin. Media and culture reagents were from Life Technologies GmbH (Karlsruhe, Germany). Con¯uent DU 145 cells were subcultured every 4 ± 5 days after detaching the cells with 0.1% trypsin, 0.02% ethylenediamine tetraacetic acid (EDTA) in phosphate buered saline (PBS). HCT116 wild type and Bax knock-out HCT116 cells (Zhang et al., 2000) were a kind gift of Bert Vogelstein (Johns Hopkins University School of Medicine, Baltimore, MD, USA). HCT116 cell clones were cultured under the same conditions as described for the DU 145 cells above.
Stable expression of Bax by retroviral infection of DU 145 cells
For expression of Bax in the Bax-negative DU 145 cells we employed the retroviral vector HyTK-Bax (Weinmann et al., 1997) which contains the human Bax-a cDNA under the control of a CMV promoter. Supernatant of the virus producing packing cell line Fly-18 (Cosset et al., 1995) was used to infect DU 145 cells in the presence of 8 mg/ml polybrene (Sigma Chemical Co., GruÈ nwald, Germany). Hygromycin (0.5 mg/ml) was added to the cells for selection 48 h later. After 3 weeks of selection the cells were subcloned. Bax expression of clones was determined by Western blot analysis as described below.
Measurement of DNA fragmentation
DNA fragmentation was measured essentially as described . After treatment for 30 h with dierent concentrations of C 2 -ceramide, cells were detached by trypsination and collected by centrifugation at 300 g for 5 min. Cells were ®rst washed with complete cell culture medium to stop tryptic digestion and then with PBS at 48C. Cells were ®xed in PBS/0.74% (v/v) formaldehyde on ice for 30 min, pelleted, incubated with ethanol/PBS (2 : 1, v/v) for 15 min, pelleted and resuspended in PBS containing 40 mg/ml RNase A. RNA was digested for 30 min at 378C. Cells were pelleted again and ®nally resuspended in PBS containing 50 mg/ ml propidium iodide. Nuclear DNA fragmentation was quanti®ed by¯ow cytometric determination of hypodiploid DNA. Data were collected and analysed using a FACScan (Becton Dickinson; Heidelberg, Germany) equipped with the CELLQuest software. Data are given in per cent of hypoploidy (subG1), which re¯ects the number of apoptotic cells.
Western blot analysis
DU 145 cells and HCT116 cells were washed twice with PBS and lysed in buer containing 10 mM Tris/HCl, pH 7.5, 300 mM NaCl, 1% Triton X-100, 2 mM MgCl 2 , 5 mM EDTA, 1 mM pepstatin, 1 mM leupeptin and 0.1 mM phenylmethylsulfonyl¯uoride (PMSF). Protein concentration was determined using the bicinchoninic acid assay (Smith et al., 1985) from Pierce (Rockford, IL, USA) and equal amounts of protein (usually 30 mg per lane) were separated by SDS ± PAGE (Laemmli, 1970) . Then, blotting of proteins onto nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany) was performed exactly as described . After blotting, the membrane was blocked for 1 h in PBST (PBS, 0.05% Tween-20) containing 3% non fat dry milk and incubated with primary antibody for 1 h. After the membrane had been washed three times in PBST, secondary antibody in PBST was applied for 1 h. Finally, the membrane was washed in PBST again and the ECL enhanced chemiluminescence system from Amersham Buchler (Braunschweig, Germany) was used to visualize the protein bands in question.
Measurement of conformational change of Bax by flow cytometry
Measurement of conformational change of Bax was performed essentially as described (Desagher et al., 1999) . After incubation for 22 h with dierent concentrations of C 2 -ceramide, mock-transfected and Bax-transfected DU 145 cells were detached by trypsination and collected by centrifugation at 300 g, 48C for 5 min. Cells were washed with PBS at 48C, ®xed in 1 ml PBS/0.5% paraformaldehyde (v/v) on ice for 30 min and washed in PBS/1% FCS. Staining with conformation speci®c anti-Bax NT antibody (Upstate biotechnology) was performed by incubating cells in 50 ml staining buer (PBS, 1% FCS, 0.1% saponin) containing 0.1 mg of the respective antibody on ice for 30 min. Then, cells were washed in staining buer, resuspended in 50 ml staining buer containing 0.1 mḡ uorescein-labelled F(ab')2 goat anti-rabbit IgG (H+L) antiserum (Jackson Immuno Research, West Grove, PA, USA) and incubated on ice for 30 min in the dark. After washing in PBS/1% FCS, intracellular staining of Bax was immediately measured with logarithmic ampli®cation in the FL-1 channel of a FACScan (Becton Dickinson). Data are given in per cent of cells with increased¯uorescence, which re¯ects the number of cells containing Bax with a conformational change in the N-terminal region.
Measurement of the mitochondrial permeability transition
After incubation for 16 h with dierent concentrations of C 2 -ceramide, DU 145 cells were detached by trypsination and collected by centrifugation at 300 g, 48C for 5 min. Mitochondrial permeability transition was then determined by staining the cells with 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-benzimidazolylcarbocyanin iodide (JC-1; Molecular Probes, Leiden, The Netherlands) exactly as described elsewhere ). Mitochondrial permeability transition was then quanti®ed by¯ow cytometric determination of cells with decreased¯uorescence, i.e. with mitochondria displaying a lower membrane potential. Data were collected and analysed using a FACScan (Becton Dickinson) equipped with the CELLQuest software. Data are given in per cent of cells with low Dc m , which re¯ects the number of cells undergoing mitochondrial apoptosis.
Measurement of cytochrome c release and processing of caspase-3
Cytosolic extracts were prepared according to a method described previously (Raisova et al., 2001) . After incubation Oncogene Ceramide-mediated apoptosis requires Bax C von Haefen et al of DU 145 cells in complete culture medium supplemented with 100 mM C 2 -ceramide or 0.25% ethanol as control for 30 h, cells were harvested in PBS, equilibrated in hypotonic buer (20 mM HEPES (pH 7.4), 10 mM KCl, 2 mM MgCl 2 , 1 mM EDTA) and centrifuged at 300 g for 5 min. The resulting cell pellets were then dissolved in hypotonic buer containing PMSF (®nal concentration 0.1 mM) and incubated on ice for 15 min. Cells were homogenized by passing the cells through a syringe (G 20) approximately 20 times. The membranes were isolated by twofold centrifugation at 10 000 g at 48C for 10 min and the supernatant of the second centrifugation was used as cytosolic extract. After determination of the protein concentration, Western blot analyses with 30 mg cytosolic protein were performed as described above and conducted with anti-cytochrome c antibodies or anticaspase-3 antibodies.
Statistical analysis
Statistical comparisons were made in these studies with Student's t-test.
